A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee

NCT02122601 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of Knee

Interventions

DRUG: LBSA0103 (BDDE cross-linked sodium hyaluronate gel)

Sponsor

LG Life Sciences